Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DALMANE DIN 00012718

Status: Cancelled Post Market
Holder: VALEANT CANADA LP / VALEANT CANADA S.E.C.
Molecule: FLURAZEPAM HYDROCHLORIDE

Health Canada record

Active ingredient(s)FLURAZEPAM HYDROCHLORIDE 30 MG
Dosage formCapsule
RouteOral
ScheduleTARGETED SUBSTANCES (CDSA IV)
ClassHuman
ATCN05CD01 FLURAZEPAM
Original market date31-Dec-1971
Current status date08-Jul-2016
SourceHealth Canada DPD

Establishment licence of the holder

Valeant Canada LP Valeant Canada S.E.C. — licence 101282, not currently licensed, last inspection rating C (2016-10-11).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FLURAZEPAM HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
00521698FLURAZEPAMAA PHARMA INCCapsuleFLURAZEPAM HYDROCHLORIDE 15 MGMarketed
00521701FLURAZEPAMAA PHARMA INCCapsuleFLURAZEPAM HYDROCHLORIDE 30 MGMarketed
02248127BIO-FLURAZEPAMBIOMED PHARMACapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market
02248126BIO-FLURAZEPAMBIOMED PHARMACapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
00012696DALMANEVALEANT CANADA LP / VALEANT CANADA S.E.C.CapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
00578479FLURAZEPAM 15PRO DOC LIMITEECapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
02232656FLURAZEPAM 15MG CAPSULELABORATOIRES CONFAB INCCapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Pre Market
00578487FLURAZEPAM 30PRO DOC LIMITEECapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market
02232657FLURAZEPAM 30MG CAPSULELABORATOIRES CONFAB INCCapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Pre Market
00496545NOVO-FLUPAM CAP 15MGNOVOPHARM LIMITEDCapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
00496553NOVO-FLUPAM CAP 30MGNOVOPHARM LIMITEDCapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market
00667102PMS-FLURAZEPAM CAP 15MGPHARMASCIENCE INCCapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
00667099PMS-FLURAZEPAM CAP 30MGPHARMASCIENCE INCCapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market
02241281RIVA-FLURAZEPAM 15MG CAPSULESLABORATOIRE RIVA INC.CapsuleFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
02241282RIVA-FLURAZEPAM 30MG CAPSULESLABORATOIRE RIVA INC.CapsuleFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market
00414239SOM-PAMBIOMED PHARMACapsuleFLURAZEPAM HYDROCHLORIDE 30 MGDormant
00414220SOM-PAMBIOMED PHARMACapsuleFLURAZEPAM HYDROCHLORIDE 15 MGDormant
00483826SOMNOL 15MGAXXESS PHARMA INC.TabletFLURAZEPAM HYDROCHLORIDE 15 MGCancelled Post Market
00483818SOMNOL 30MGAXXESS PHARMA INC.TabletFLURAZEPAM HYDROCHLORIDE 30 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
68052005-05-16New Drug Submission (NDS)MANUFACTURER NAME CHANGE
28841998-12-21New Drug Submission (NDS)MANUFACTURER NAME CHANGE

International API supply for FLURAZEPAM HYDROCHLORIDE

1 active FDA Drug Master Files.

Request a quote for DALMANE

How to read a Canadian DIN record